KPTI Karyopharm Therapeutics Inc
$1.62
Karyopharm Therapeutics Inc (KPTI) Earnings News
Earnings press releases, previews and reviews for Karyopharm Therapeutics Inc (KPTI), newest first.
Thursday
August 13, 2026
7:30 AM ET
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
Monday
August 10, 2026
7:30 AM ET
Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026
Monday
June 1, 2026
7:30 AM ET
Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation
Thursday
May 14, 2026
7:30 AM ET
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
Thursday
May 7, 2026
7:30 AM ET
Karyopharm to Report First Quarter 2026 Financial Results on May 14, 2026